BRTX — BIORESTORATIVE THERAPIES INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
About BIORESTORATIVE THERAPIES INC (BRTX)
BIORESTORATIVE THERAPIES INC (BRTX) appears in the most recent 13F filings of 1 tracked institutional investor. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $151,880. Across recent filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in BRTX
How many top investors track BRTX
Only 1 tracked investor report this position.
BRTX Ownership Composition
How BIORESTORATIVE THERAPIES INC is held across tracked investor types, based on reported 13F positions.
- Other100.0%
Tracked investors reporting BRTX
- Ken GriffinMar 31, 2026Citadel AdvisorsShares238.6KValue$64.9K% Portfolio0.00%
Recent activity
- New$64.9KMay 15, 2026
- New$151.9KNov 14, 2025
Frequently asked questions
- How many institutional investors hold BRTX?
- 1 tracked institutional investor disclosed a position in BRTX (BIORESTORATIVE THERAPIES INC) in their most recent 13F filing.
- Who is the largest institutional holder of BRTX?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in BRTX, valued at $151,880.
- Did institutional ownership of BRTX increase or decrease?
- Across recent 13F filings, tracked investors recorded 2 new positions, 0 increased, 0 reduced, and 0 fully exited BRTX.
- Where does this BRTX ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.